ERIK DOMINGUES, Erik Domingues, MD FAAD

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Speaker
    Ineligible company:
    Abbvie
    Topic:
    vitiligo
    Date added:
    05/11/2026
    Date updated:
    05/11/2026
  • Attribution:
    Self
    Type of financial relationship:
    Consultant
    Ineligible company:
    Abbvie
    Topic:
    vitiligo
    Date added:
    05/11/2026
    Date updated:
    05/11/2026
  • Attribution:
    Self
    Type of financial relationship:
    Consultant
    Ineligible company:
    Arcutis
    Topic:
    psoriasis, AD, seborrheic dermatitis
    Date added:
    05/11/2026
    Date updated:
    05/11/2026
  • Attribution:
    Self
    Type of financial relationship:
    Speaker
    Ineligible company:
    Arcutis
    Topic:
    psoriasis, AD, seborrheic dermatitis
    Date added:
    05/11/2026
    Date updated:
    05/11/2026
  • Attribution:
    Self
    Type of financial relationship:
    Advisor
    Ineligible company:
    BMS
    Topic:
    psoriasis
    Date added:
    05/11/2026
    Date updated:
    05/11/2026
    Relationship end date:
    10/01/2025
  • Attribution:
    Self
    Type of financial relationship:
    Speaker
    Ineligible company:
    BMS
    Topic:
    psoriasis
    Date added:
    05/11/2026
    Date updated:
    05/11/2026
    Relationship end date:
    10/01/2025
  • Attribution:
    Self
    Type of financial relationship:
    Advisor
    Ineligible company:
    Castle Biosciences
    Topic:
    Decisiondx
    Date added:
    05/11/2026
    Date updated:
    05/11/2026
  • Attribution:
    Self
    Type of financial relationship:
    Advisor
    Ineligible company:
    Incyte
    Topic:
    vitiligo, atopic dermatitis
    Date added:
    05/11/2026
    Date updated:
    05/11/2026
  • Attribution:
    Self
    Type of financial relationship:
    Speaker
    Ineligible company:
    Incyte
    Topic:
    vitiligo, atopic dermatitis
    Date added:
    05/11/2026
    Date updated:
    05/11/2026
  • Attribution:
    Self
    Type of financial relationship:
    Speaker
    Ineligible company:
    Galderma
    Topic:
    atopic dermatitis, prurigo nodularis
    Date added:
    05/11/2026
    Date updated:
    05/11/2026

Pages

Return to 4th Annual Northeast Dermatology Regional Conference